Bright Green Corporation

OTCPK:BGXX.Q Stock Report

Market Cap: US$38.2k

Bright Green Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Bright Green's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth5.95%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Seeking Alpha • Sep 08

Bright Green climbs 9% premarket on pricing of $10M private placement

Bright Green (NASDAQ:BGXX) gains 9% premarket on entering into a securities purchase agreement with institutional investors to purchase 9,523,810 shares of common stock and warrants, at a purchase price of $1.05/share and accompanying warrant. The gross proceeds are expected to be ~$10M before deducting the placement agent's fees and other estimated offering expenses. The warrants will be immediately exercisable from the date of issuance at an initial exercise price of $1.05/share and will expire five years from the date of issuance. The closing of the private placement is expected to occur on September 12, 2022.
Seeking Alpha • Jul 01

Bright Green chief executive steps down

Bright Green (NASDAQ:BGXX) announced that Ed Robinson is stepping down as CEO and as a member of the Board of Directors, to pursue other opportunities.  Mr. Robinson will remain with the company as a capital markets advisor through 2023.  Until a successor is named, the Board has appointed Chairman of the Board, Terry Rafih, as Interim CEO. Search for a permanent CEO has been initiated.

Revenue & Expenses Breakdown

How Bright Green makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:BGXX.Q Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-950
30 Jun 240-1060
31 Mar 240-1170
31 Dec 230-1380
30 Sep 230-1080
30 Jun 230-13120
31 Mar 230-30280
31 Dec 220-28270
30 Sep 220-27260
30 Jun 220-21210
31 Mar 220-320
31 Dec 210-220
30 Sep 210-210
30 Jun 210-320
31 Mar 210-320
31 Dec 200-320

Quality Earnings: Insufficient data to determine if BGXX.Q has high quality earnings.

Growing Profit Margin: Insufficient data to determine if BGXX.Q's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if BGXX.Q's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare BGXX.Q's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if BGXX.Q's earnings growth over the past year exceeded the Pharmaceuticals industry average.

Return on Equity

High ROE: BGXX.Q has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/28 03:26
End of Day Share Price 2026/06/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bright Green Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.